Andreas Holstein
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
Papers in ⓘ
-
- Diabetes Management and Research 25
- Diabetes Treatment and Management 19
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 16
-
- Metabolism, Diabetes, and Cancer 10
- Co-authors
- E.‐H. Egberts (16 shared papers)A. Plaschke (13 shared papers)Péter Kovács (15 shared papers)Michael Stümvoll (8 shared papers)Michael Hahn (4 shared papers)Winfried Beil (3 shared papers)Magdalena Ptak (3 shared papers)J. Brockmöller (1 shared paper)
- Journals
- Experimental and Clinical Endocrinology & Diabetes (8 papers)European Journal of Clinical Pharmacology (3 papers)Diabetic Medicine (2 papers)Expert Opinion on Drug Metabolism & Toxicology (2 papers)Acta Diabetologica (2 papers)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Andreas Holstein
49 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 89
- Endocrinology, Diabetes and Metabolism 1.0k
- Pharmacology 157
- Hepatology 92
- Genetics 218
- Surgery 345
Countries citing papers authored by Andreas Holstein
This map shows the geographic impact of Andreas Holstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Holstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Holstein more than expected).
Fields of papers citing papers by Andreas Holstein
This network shows the impact of papers produced by Andreas Holstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Holstein. The network helps show where Andreas Holstein may publish in the future.
Co-authors
The 25 scholars most cited alongside Andreas Holstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 190 | |
| 2 | 2002 | 163 | |
| 3 | 2005 | 105 | |
| 4 | 2005 | 102 | |
| 5 | 1999 | 98 | |
| 6 | 2003 | 98 | |
| 7 | 2003 | 88 | |
| 8 | 2010 | 55 | |
| 9 | 2012 | 51 | |
| 10 | 2003 | 50 | |
| 11 | 2011 | 48 | |
| 12 | 2009 | 45 | |
| 13 | 2009 | 42 | |
| 14 | 2011 | 42 | |
| 15 | 2009 | 41 | |
| 16 | 2012 | 39 | |
| 17 | 2000 | 22 | |
| 18 | 2012 | 18 | |
| 19 | 2003 | 17 | |
| 20 | 2001 | 13 |
About Andreas Holstein
Andreas Holstein is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology, Surgery, Genetics and Pulmonary and Respiratory Medicine, having authored 52 papers that have together received 1.5k indexed citations. Recurring topics across this work include Diabetes Management and Research (25 papers), Diabetes Treatment and Management (19 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (16 papers), Metabolism, Diabetes, and Cancer (10 papers), Diabetes and associated disorders (9 papers), Pancreatic function and diabetes (8 papers), Botulinum Toxin and Related Neurological Disorders (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.0k citations), Pharmacology (157 citations), Hepatology (92 citations), Genetics (218 citations) and Surgery (345 citations). Andreas Holstein has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include E.‐H. Egberts, A. Plaschke, Péter Kovács, Michael Stümvoll, Michael Hahn, Winfried Beil, Magdalena Ptak, J. Brockmöller, Julia Kirchheiner and H. Stege. Their work appears in journals such as Experimental and Clinical Endocrinology & Diabetes, European Journal of Clinical Pharmacology, Diabetic Medicine, Expert Opinion on Drug Metabolism & Toxicology and Acta Diabetologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.